The optimal revascularization strategy for multivessel coronary artery disease: the debate continues

Ivan P Casserly1

  • 1Interventional Cardiology, Denver Veterans Affairs Medical Center, Colorado 80220, USA. ivan.casserly@med.va.gov

Insights

Mortality rates were lower for coronary artery bypass grafting (CABG) than percutaneous coronary intervention (PCI) in multivessel coronary artery disease patients. This registry finding contrasts with randomized trials showing equivalent outcomes, raising questions about treatment choices.

Area of Science:

  • Cardiology
  • Health Services Research

Background:

  • Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) are primary revascularization strategies for coronary artery disease (CAD).
  • Previous randomized controlled trials (RCTs) indicated similar mortality rates between CABG and PCI for multivessel CAD.
  • Real-world data may offer different perspectives on comparative effectiveness.

Purpose of the Study:

  • To compare the long-term mortality outcomes of CABG versus PCI in patients with multivessel coronary artery disease using a large state registry.
  • To investigate potential discrepancies between observational data and RCT findings in CAD treatment outcomes.

Main Methods:

  • Analysis of New York State patient registry data.
  • Comparison of mortality rates between patients undergoing CABG and those undergoing PCI for multivessel CAD.
  • Statistical adjustment for patient characteristics and comorbidities.

Main Results:

  • Patients with multivessel CAD who underwent CABG experienced lower mortality rates compared to those who underwent PCI.
  • This finding contrasts with the established results from major randomized controlled trials.

Conclusions:

  • Observational data from state registries suggest a potential survival benefit for CABG over PCI in multivessel CAD.
  • Further investigation is warranted to reconcile the differences between registry data and RCT findings.
  • Clinical decision-making for multivessel CAD revascularization requires careful consideration of evidence from diverse sources.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...